Delattre O - Search Results

1

The tumor suppressor hSNF5/INI1 modulates cell growth and actin cytoskeleton organization.

Medjkane S, Novikov E, Versteege I, Delattre O. Medjkane S, et al. Among authors: delattre o. Cancer Res. 2004 May 15;64(10):3406-13. doi: 10.1158/0008-5472.CAN-03-3004. Cancer Res. 2004. PMID: 15150092

2

Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer.

Versteege I, Sévenet N, Lange J, Rousseau-Merck MF, Ambros P, Handgretinger R, Aurias A, Delattre O. Versteege I, et al. Among authors: delattre o. Nature. 1998 Jul 9;394(6689):203-6. doi: 10.1038/28212. Nature. 1998. PMID: 9671307

3

hSNF5/INI1 inactivation is mainly associated with homozygous deletions and mitotic recombinations in rhabdoid tumors.

Rousseau-Merck MF, Versteege I, Legrand I, Couturier J, Mairal A, Delattre O, Aurias A. Rousseau-Merck MF, et al. Among authors: delattre o. Cancer Res. 1999 Jul 1;59(13):3152-6. Cancer Res. 1999. PMID: 10397258

4

Constitutional mutations of the hSNF5/INI1 gene predispose to a variety of cancers.

Sévenet N, Sheridan E, Amram D, Schneider P, Handgretinger R, Delattre O. Sévenet N, et al. Among authors: delattre o. Am J Hum Genet. 1999 Nov;65(5):1342-8. doi: 10.1086/302639. Am J Hum Genet. 1999. PMID: 10521299 Free PMC article.

5

Spectrum of hSNF5/INI1 somatic mutations in human cancer and genotype-phenotype correlations.

Sévenet N, Lellouch-Tubiana A, Schofield D, Hoang-Xuan K, Gessler M, Birnbaum D, Jeanpierre C, Jouvet A, Delattre O. Sévenet N, et al. Among authors: delattre o. Hum Mol Genet. 1999 Dec;8(13):2359-68. doi: 10.1093/hmg/8.13.2359. Hum Mol Genet. 1999. PMID: 10556283

6

INI1 mutations in meningiomas at a potential hotspot in exon 9.

Schmitz U, Mueller W, Weber M, Sévenet N, Delattre O, von Deimling A. Schmitz U, et al. Among authors: delattre o. Br J Cancer. 2001 Jan;84(2):199-201. doi: 10.1054/bjoc.2000.1583. Br J Cancer. 2001. PMID: 11161377 Free PMC article.

7

A key role of the hSNF5/INI1 tumour suppressor in the control of the G1-S transition of the cell cycle.

Versteege I, Medjkane S, Rouillard D, Delattre O. Versteege I, et al. Among authors: delattre o. Oncogene. 2002 Sep 19;21(42):6403-12. doi: 10.1038/sj.onc.1205841. Oncogene. 2002. PMID: 12226744

8

Gene expression profiling of 1p35-36 genes in neuroblastoma.

Janoueix-Lerosey I, Novikov E, Monteiro M, Gruel N, Schleiermacher G, Loriod B, Nguyen C, Delattre O. Janoueix-Lerosey I, et al. Among authors: delattre o. Oncogene. 2004 Aug 5;23(35):5912-22. doi: 10.1038/sj.onc.1207784. Oncogene. 2004. PMID: 15195138

9

EWS/FLI-1 silencing and gene profiling of Ewing cells reveal downstream oncogenic pathways and a crucial role for repression of insulin-like growth factor binding protein 3.

Prieur A, Tirode F, Cohen P, Delattre O. Prieur A, et al. Among authors: delattre o. Mol Cell Biol. 2004 Aug;24(16):7275-83. doi: 10.1128/MCB.24.16.7275-7283.2004. Mol Cell Biol. 2004. PMID: 15282325 Free PMC article.

10

Chromosome mechanisms and INI1 inactivation in human and mouse rhabdoid tumors.

Rousseau-Merck MF, Fiette L, Klochendler-Yeivin A, Delattre O, Aurias A. Rousseau-Merck MF, et al. Among authors: delattre o. Cancer Genet Cytogenet. 2005 Mar;157(2):127-33. doi: 10.1016/j.cancergencyto.2004.06.006. Cancer Genet Cytogenet. 2005. PMID: 15721633

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

489 results

Search Page

Filters